The best age and time to get treatment is as soon as you start noticing the signs of genetic alopecia. Contrary to popular belief, genetic alopecia can affect any person between the ages of 12 to 40. Men and women see different patterns of baldness but the very first common sign is excessive hair loss. 1 in every 50 person suffers from genetic alopecia at some point of his or her life. Early intervention can save you with the devastating psychosocial impact of premature balding.
The QR678 research & development platform technology is a proprietary first-in-class technology. This science backed technology is giving rise to multiple products that arrest hair fall and address the thickness, density of hair follicles leading to greater coverage in hair loss. This R&D technology deals with multiple human hair growth related growth factors that are naturally present in our scalp making products derived from these completely natural. Research on this platform technology has resulted in this being awarded USA & Indian patents and has led to over 13+ clinical research papers being published with products derived from this unique technology. The hair growth factors penetrate deep into the scalp and provide nourishment to the scale. Unlike other treatments that contains harmful medication, products derived from QR678 are almost completely devoid of side effects.
HOW DOES IT WORK?
QR678® 2019-26. Owned by Esthetic Products International LLP, Sofia, Bulgaria.
The QR678® research & development product platform technology is developing a group of patented, proprietary products. Any infringement of any kind will invite legal action.
Geographies Addressed: Bulgaria, European Union, Kuwait, Malaysia, Qatar, Oman, Serbia, India
Registration process underway: Canada, Phillipines, UAE, South Africa, Uganda, Indonesia, Singapore, Srilanka, Maldives, Bangladesh, Pakistan, Nepal
Disclaimer: QR678® is a proprietary research and technology platform focused on scientific innovation in hair and scalp science.
This website is intended solely for the dissemination of scientific, educational, and informational content relating to research and technology development. It does not offer products for sale, nor does it provide medical or therapeutic advice.